NEWS ALERT June 2nd 2021:
******** U.S. Stem Cell Inc. LOSES THEIR 11th CIRCUIT FEDERAL APPEAL********
"
III. Conclusion
For these reasons, neither the same surgical procedure exception nor the 361 HCT/Ps exception applies to the Clinic’s surgical practice. The Clinic did not challenge the district court’s judgment upon any other ground. Accordingly, we AFFIRM the judgment of the district court."
https://media.ca11.uscourts.gov/opinions/pub/files/201913276.pdf
https://www.sun-sentinel.com/business/fl-bz-us-stem-cell-loses-appeal-of-shutdown-20210603-bft7txqtkvb5hc5lzgemzh7niu-story.html
https://news.yahoo.com/sunrise-stem-cell-clinic-loses-193500517.html
U.S. Stem Cell Clinic LLC (1290 Weston Rd Suite 230A, Weston, FL 33326) is now under PERMANANT INJUNCTION as issued by the FDA w/ legal backing of the DOJ (U.S. Department of Justice)
https://usstemcellclinic.com/
________________________________________________________________________________________________________________________________________________________________________
STOCK INFORMATION:
https://www.otcmarkets.com/stock/USRM/overview
Symbol: $USRM
(Formerly named Bioheart and former trading symbol $BHRT)
OTC Markets Site: WARNING OTC RED STOP SIGN "PINK NO INFORMATION" and GROSSLY DELINQUENT IN THEIR SEC FILING OBLIGATIONS !!
Company is not current in its reporting obligations under Section 13 or 15(d) of the Exchange Act.
As of June 14th, 2021 USRM is missing and grossly delinquent on "Timely filing" of the following Qty-6 SEC LEGALLY REQUIRED FILINGS -
1) 2019 SEC 10-K Annual Report (audit required) due March 31st, 2020
2) 2020 SEC 10-Q for Q-1 due May 15th, 2020
3) 2020 SEC 10-Q for Q-2 due July 15th, 2020
4) 2020 SEC 10-Q for Q-3 due Oct 15th, 2020
5) 2020 SEC 10-K Annual Report (Audit required) due March 31st 2021
6) 2021 SEC 10-Q for Q-1 due May 15th, 2021
Main Corporate Website: http://us-stemcell.com/
All SEC filings for $USRM can be found here on the SEC EDGAR database:
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001388319&owner=exclude&count=40&hidefilings=0
___________________________________________________________________________________________________________________________________________________________________________
Management: Executive Officers and Directors Set forth below is information regarding U.S. Stem Cell Inc. executive officers and directors as of March 10, 2022 | Name | Age | Title |
| Mark P. Borman | 68 | Director, Chairman of the Board |
| Mike (Michael) Tomas | 57 | Director, President and Chief Executive Officer, Chief Financial Officer |
| Gregory Knutson | 68 | Director |
| Sheldon T. Anderson | 72 | Director |
| | | |
| William P. Murphy, Jr. M.D. | 98 | Former Chairman Of The Board (Retired and replaced by Borman on March 4, 2022) |
| Kristen Comella | 46 | Former Director and former "chief science officer" |
_____________________________________________________________________________________________________________________________________________________
U.S. Stem Cell, Inc.
1560 Sawgrass Corporate Pkwy
4th Floor
Sunrise FL, 33323
Phone: 954-835-1500
Former address until 9/30/2019 was: 13794 NW 4th Street, Suite 212, Sunrise, Florida 33325